Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C8H13N5O4 |
Molecular Weight | 243.2199 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=N)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
InChI
InChIKey=NHKZSTHOYNWEEZ-AFCXAGJDSA-N
InChI=1S/C8H13N5O4/c9-6(10)7-11-2-13(12-7)8-5(16)4(15)3(1-14)17-8/h2-5,8,14-16H,1H2,(H3,9,10)/t3-,4-,5-,8-/m1/s1
Molecular Formula | C8H13N5O4 |
Molecular Weight | 243.2199 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Taribavirin, an oral prodrug of ribavirin that was developed as nucleoside antimetabolite, which interferes with duplication of viral genetic material. Taribavirin was studied in phase III clinical trial for the treatment of chronic hepatitis C patients. However, this drug not yet approved for pharmaceutical use.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Viramidine (Ribapharm). | 2002 Nov |
|
A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. | 2004 Apr |
|
Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study. | 2007 Jul |
|
Therapeutic issues in HIV/HCV-coinfected patients. | 2007 Jun |
|
A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results. | 2009 Sep |
|
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents. | 2010 |
|
Hepatitis C and kidney disease. | 2010 |
|
The next step for taribavirin. | 2010 Oct |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00230958
viramidine (TARIBAVIRIN) 600 mg BID
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:04:23 UTC 2023
by
admin
on
Fri Dec 15 16:04:23 UTC 2023
|
Record UNII |
R3B1994K2E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C281
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
119567-79-2
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
C76499
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
DB06408
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
3582
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
451448
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
8619
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
100000087327
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
CHEMBL2111108
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
DTXSID80894181
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
R3B1994K2E
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
TARIBAVIRIN
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | |||
|
m10467
Created by
admin on Fri Dec 15 16:04:24 UTC 2023 , Edited by admin on Fri Dec 15 16:04:24 UTC 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |